Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Cancer therapy

May 25, 2026 CD as API / Pharma applications

CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation

This review critically examines how cyclodextrins modulate regulated cell death pathways and the implications for immunometabolism and therapeutic translation. Increasing

Continue reading

May 11, 2026 CD as API / CD derivatives / Drug delivery / Pharma applications

Sugammadex analog water soluble BCD polymer for peptide complexes

In this work, an integrated biophysical and biological study is presented describing both the structural and biological features of the

Continue reading

March 27, 2026 CD derivatives / Drug delivery

Potential Glioblastoma Therapy with Cationic Cyclodextrin Polymers as Drug Delivery Excipients

Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months despite

Continue reading

January 29, 2026 Drug delivery / Pharma applications

Poly(β-cyclodextrin)-coated dysprosium-doped ZnS nanocarriers

This study provides a comprehensive analysis of the structures and properties of zinc sulfide (ZnS) and dysprosium-doped ZnS nanoparticles (NPs)

Continue reading

January 21, 2026 Drug delivery / Pharma applications

pH-responsive magnetic cyclodextrin-liposome nanoplatforms for stabilization and targeted delivery of topotecan

Topotecan (TPT), a potent anticancer agent, suffers from rapid hydrolysis of its active lactone ring under physiological conditions, severely limiting

Continue reading

November 11, 2025 Drug delivery / Pharma applications

Cyclodextrin complexation of selected tyrosine kinase inhibitors

The comprehensive physicochemical characterization and cyclodextrin complexation of four tyrosine kinase inhibitors — erlotinib, gefitinib, vandetanib, and lapatinib — were

Continue reading

October 29, 2025 Drug delivery / Pharma applications

Cyclodextrin-Based Supramolecular Hydrogels in Therapy

Injectable biopolymer-based hydrogels have emerged as a powerful class of biomaterials designed for minimally invasive therapeutic strategies in modern medicine.

Continue reading

October 17, 2025 Drug delivery / Events / Pharma applications

Supramolecular Nanomedicine for Cancer: Research, Collaboration, and Dialogue – First Online Workshop of the NextNano4Cancer project

This workshop is part of the NextNano4Cancer project, funded under the ERA4Health Joint Transnational Call “Nano and advanced technologies for

Continue reading

October 7, 2025 Drug delivery / Pharma applications

Beta cyclodextrin stabilized cupric oxide nanoparticles assisted thermal therapy for lung tumor and its effective in vitro anticancer activity

The unique physicochemical properties of cupric oxide nanoparticles (CuO NPs) make them suitable for a wide range of therapeutic applications.

Continue reading

September 29, 2025 Drug delivery / Pharma applications

Fe3O4@β-cyclodextrin Nanosystem for melanoma treatment

The high occurrence of melanoma and its associated poor prognosis highlight the need for exploring new and innovative treatment strategies.

Continue reading

Posts pagination

1 2 3 … 9 Next Posts»

Recent Posts

  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (71)
  • CD as API (348)
  • CD derivatives (417)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (798)
  • E-ducation (63)
  • Environmental (138)
  • Events (234)
  • Food (225)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (109)
  • Pharma applications (1,191)
  • Supramolecular systems (42)
  • Uncategorized (153)

Top Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • GRAS status of CD derivatives
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Citric acid cross-linked β-cyclodextrins: A review of preparation and environmental/biomedical application
  • A Cyclodextrin Surprise in a Japanese Supplement

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...